Narci Teoh

4.8k total citations · 1 hit paper
50 papers, 3.8k citations indexed

About

Narci Teoh is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Narci Teoh has authored 50 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 23 papers in Hepatology and 16 papers in Surgery. Recurrent topics in Narci Teoh's work include Liver Disease Diagnosis and Treatment (23 papers), Liver Disease and Transplantation (15 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Narci Teoh is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Liver Disease and Transplantation (15 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Narci Teoh collaborates with scholars based in Australia, United States and China. Narci Teoh's co-authors include Geoffrey C. Farrell, Matthew M. Yeh, Derrick M. Van Rooyen, George N. Ioannou, Geoff Farrell, Robert S. McCuskey, Auvro R. Mridha, Aileen Dela Peňa, Christopher Savard and Fahrettin Haczeyni and has published in prestigious journals such as Journal of Biological Chemistry, Nature Immunology and Gastroenterology.

In The Last Decade

Narci Teoh

48 papers receiving 3.7k citations

Hit Papers

NLRP3 inflammasome blockade reduces liver inflammation an... 2017 2026 2020 2023 2017 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Narci Teoh Australia 30 2.0k 1.4k 1.1k 955 592 50 3.8k
Chiara Rosso Italy 29 2.3k 1.2× 946 0.7× 933 0.9× 437 0.5× 881 1.5× 140 3.5k
Tadashi Namisaki Japan 29 1.5k 0.8× 952 0.7× 1.2k 1.1× 500 0.5× 539 0.9× 159 3.3k
Juan Caballería Spain 33 2.5k 1.3× 1.2k 0.9× 1.1k 1.0× 551 0.6× 757 1.3× 67 4.1k
Karen Louise Thomsen Denmark 27 2.1k 1.0× 574 0.4× 1.1k 1.0× 625 0.7× 583 1.0× 104 3.0k
Francisco Javier Cubero Spain 32 1.3k 0.6× 937 0.7× 793 0.7× 404 0.4× 247 0.4× 90 2.9k
Junping Shi China 30 2.0k 1.0× 922 0.7× 842 0.8× 295 0.3× 723 1.2× 163 3.3k
Kazuhisa Tsukamoto Japan 30 911 0.5× 1.6k 1.2× 510 0.5× 960 1.0× 723 1.2× 103 3.5k
Hae‐Ki Min United States 21 1.7k 0.9× 1.2k 0.9× 351 0.3× 461 0.5× 642 1.1× 33 3.0k
Bryan L. Copple United States 31 1.5k 0.8× 1.1k 0.8× 1.1k 1.0× 606 0.6× 157 0.3× 59 3.5k
Martin Wagner Austria 41 2.6k 1.3× 1.2k 0.8× 1.8k 1.6× 2.2k 2.3× 375 0.6× 81 6.2k

Countries citing papers authored by Narci Teoh

Since Specialization
Citations

This map shows the geographic impact of Narci Teoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narci Teoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narci Teoh more than expected).

Fields of papers citing papers by Narci Teoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narci Teoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narci Teoh. The network helps show where Narci Teoh may publish in the future.

Co-authorship network of co-authors of Narci Teoh

This figure shows the co-authorship network connecting the top 25 collaborators of Narci Teoh. A scholar is included among the top collaborators of Narci Teoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narci Teoh. Narci Teoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Arfianti, Arfianti, Sharon Pok, W. Geoffrey Haigh, et al.. (2020). Exercise retards hepatocarcinogenesis in obese mice independently of weight control. Journal of Hepatology. 73(1). 140–148. 34 indexed citations
4.
Golen, Rowan F. van, Megan J. Reiniers, Gerben Marsman, et al.. (2019). The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1192–1200. 26 indexed citations
5.
Teoh, Narci, et al.. (2019). When the liver gets stiff, the tough get moving. Journal of Gastroenterology and Hepatology. 35(6). 953–959. 4 indexed citations
6.
Mridha, Auvro R., Alexander Wree, Avril A. B. Robertson, et al.. (2017). NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. Journal of Hepatology. 66(5). 1037–1046. 863 indexed citations breakdown →
7.
Pok, Sharon, et al.. (2017). Deriving and testing of dysplastic murine hepatocytes: A new platform in liver cancer research. Experimental Cell Research. 356(1). 48–56. 1 indexed citations
8.
Ioannou, George N., Derrick M. Van Rooyen, Christopher Savard, et al.. (2014). Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH. Journal of Lipid Research. 56(2). 277–285. 75 indexed citations
9.
Larter, Claire Z., Matthew M. Yeh, W. Geoffrey Haigh, et al.. (2013). Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease. Obesity. 21(6). 1189–1199. 29 indexed citations
10.
Pok, Sharon, Nicholas Shackel, Amber E. Alsop, et al.. (2013). Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis. Journal of Gastroenterology and Hepatology. 28(9). 1545–1554. 28 indexed citations
11.
Yabas, Mehmet, Charis E. Teh, Sandra Frankenreiter, et al.. (2011). ATP11C is critical for the internalization of phosphatidylserine and differentiation of B lymphocytes. Nature Immunology. 12(5). 441–449. 102 indexed citations
12.
Teoh, Narci, Geoffrey C. Farrell, & Henry LY Chan. (2010). Individualisation of antiviral therapy for chronic hepatitis C. Journal of Gastroenterology and Hepatology. 25(7). 1206–1216. 16 indexed citations
13.
Teoh, Narci. (2009). Proliferative drive and liver carcinogenesis: Too much of a good thing?. Journal of Gastroenterology and Hepatology. 24(12). 1817–1825. 16 indexed citations
15.
Teoh, Narci, Yock Young Dan, Karen Swisshelm, et al.. (2008). Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice. Hepatology. 47(6). 2078–2088. 70 indexed citations
16.
Farrell, Geoff, Narci Teoh, & Robert S. McCuskey. (2008). Hepatic Microcirculation in Fatty Liver Disease. The Anatomical Record. 291(6). 684–692. 198 indexed citations
17.
Teoh, Narci, Yoshiya Ito, Jacqueline Field, et al.. (2007). Diannexin, a Novel Annexin V Homodimer, Provides Prolonged Protection Against Hepatic Ischemia-Reperfusion Injury in Mice. Gastroenterology. 133(2). 632–646. 61 indexed citations
18.
Qiao, Liang, Baohong Zhang, Hongxia Zhang, et al.. (2005). Ethanol reduces p38 kinase activation and cyclin D1 protein expression after partial hepatectomy in rats. Journal of Hepatology. 44(2). 375–382. 33 indexed citations
19.
Teoh, Narci & Geoffrey C. Farrell. (2003). Hepatotoxicity associated with non-steroidal anti-inflammatory drugs. Clinics in Liver Disease. 7(2). 401–413. 55 indexed citations
20.
Teoh, Narci, Isabelle Leclercq, Aileen Dela Peňa, & Geoffrey C. Farrell. (2003). Low-dose TNF-α protects against hepatic ischemia-reperfusion injury in mice: Implications for preconditioning. Hepatology. 37(1). 118–128. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026